HASH Fundamental Analysis - SIMPLY SOLVENTLESS CONCENTRA

Fundamental Rating

Overall HASH gets a fundamental rating of 1 out of 10. We evaluated HASH against 35 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HASH have multiple concerns. HASH does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

HASH had negative earnings in the past year.

HASH had a negative operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of -12.15%, HASH is in line with its industry, outperforming 42.86% of the companies in the same industry.

HASH has a worse Return On Equity (-30.35%) than 60.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-12.15%
ROE	-30.35%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of HASH (14.39%) is worse than 74.29% of its industry peers.

The Profit Margin and Operating Margin are not available for HASH so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	14.39%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HASH does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for HASH has been increased compared to 1 year ago.

HASH has a worse debt/assets ratio than last year.

2.2 Solvency

HASH has an Altman-Z score of 0.46. This is a bad value and indicates that HASH is not financially healthy and even has some risk of bankruptcy.

HASH has a better Altman-Z score (0.46) than 68.57% of its industry peers.

HASH has a Debt/Equity ratio of 0.62. This is a neutral value indicating HASH is somewhat dependend on debt financing.

The Debt to Equity ratio of HASH (0.62) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.62
Debt/FCF	N/A
Altman-Z	0.46

ROIC/WACCN/A

WACC8.6%

2.3 Liquidity

A Current Ratio of 1.08 indicates that HASH should not have too much problems paying its short term obligations.

With a Current ratio value of 1.08, HASH is not doing good in the industry: 71.43% of the companies in the same industry are doing better.

A Quick Ratio of 0.33 indicates that HASH may have some problems paying its short term obligations.

The Quick ratio of HASH (0.33) is worse than 85.71% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.08
Quick Ratio	0.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HASH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -410.40%.

Looking at the last year, HASH shows a very strong growth in Revenue. The Revenue has grown by 120.93%.

EPS 1Y (TTM)-410.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)120.93%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HASH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HASH does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SIMPLY SOLVENTLESS CONCENTRA

TSX-V:HASH (6/27/2025, 7:00:00 PM)

0.21

+0.01 (+2.44%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)05-09 2025-05-09

Earnings (Next)08-13 2025-08-13

Inst Owners0.29%

Inst Owner ChangeN/A

Ins Owners10.69%

Ins Owner ChangeN/A

Market Cap22.81M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.43
P/FCF	N/A
P/OCF	N/A
P/B	1.48
P/tB	6.3
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.06

FCFYN/A

OCF(TTM)-0.05

OCFYN/A

SpS0.15

BVpS0.14

TBVpS0.03

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-12.15%
ROE	-30.35%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	14.39%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score1

Asset Turnover0.41

Health

		Industry Rank	Sector Rank
Debt/Equity	0.62
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	122.12%
Cap/Sales	1.92%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.08
Quick Ratio	0.33
Altman-Z	0.46

F-Score1

WACC8.6%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-410.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)120.93%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-302.67%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-1009.32%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1332.95%

OCF growth 3YN/A

OCF growth 5YN/A

SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens